Case Study

Medable Enables >90% eCOA Adherence In Vaccine Trial

Source: Medable
Woman using cell phone 1263380081

When a prominent biotech firm approached Medable to facilitate a vaccine trial, they expressed concerns regarding the acceptance and engagement of their chosen eCOAtrial technology among participants aged 50 years and above. They feared potential disengagement leading to inconsistent trial data.

Discover how Medable addressed these challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants and yielding consistent, reliable trial data.

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

Medable